Coming Soon

Season 1: Network Effects
Unlock exponential growth
Master the 16 network effects
20 years of insights in one class

Investing Profile

Tom Woiwode

VC

Photo of Tom Woiwode, Managing Partner at Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Versant Ventures Managing Partner
7
$102.2M
CompanyStageDateRound SizeTotal Raised
Tempest Therapeutics
Series BMar 2018$70M
$70M
Co-investors: Robert Weisskoff (F-Prime Capital Partners)
Gritstone Oncology
Series BSep 2017$93M
Series AOct 2015$100M
$200M
Co-investors: Peter Svennilson (The Column Group), Anthony Philippakis (GV)
Vividion Therapeutics
Series AFeb 2017$50M
$130M
Co-investors: Jakob Loven (Nextech Invest), Kristina Burow (ARCH Venture Partners)
Therachon
Series AJan 2017$5M
$40M
Co-investors: Stephen Squinto (OrbiMed), Sara Nayeem (Avoro Ventures)
Anokion
Series AMay 2014$38M
$38M
Co-investors: Florent Gros (Earlybird Venture Capital), Jack Nielsen (Vivo Capital)
Saegis Pharmaceuticals
Series BNov 2003$30M
$30M